Form 4: H.B. Fuller Executive Campe Reports Acquisition of Phantom Units and Dividend Reinvestment
SEC Form 4
Heather Campe, Sr. VP of International Growth at H.B. Fuller, reports the acquisition of phantom units and shares through dividend reinvestment.
Summary
- Heather Campe, a Senior Vice President at H.B. Fuller, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- The report includes the acquisition of phantom units that convert into common stock, as well as shares acquired through a dividend reinvestment plan.
- Campe also holds employee stock options and restricted stock units that vest over time.
- The reported transactions do not involve the sale of any securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing showing an executive's transactions, with no clear positive or negative implications for the company's performance.
Positives
- The reporting person's acquisition of phantom units and shares through dividend reinvestment indicates a continued investment in the company's future.
- The executive holds a significant number of vested and unvested stock options, aligning her interests with those of shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the executive's continued investment in the company.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the transactions of a key executive.
- The executive's continued investment in the company may signal confidence to employees.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Date of employee stock option grant with an exercise price of $50.1 and expiration on 01/26/2027. |
| 01/25/2019 | Date of employee stock option grant with an exercise price of $53.57 and expiration on 01/25/2028. |
| 01/27/2022 | Date of employee stock option grant with an exercise price of $51.89 and expiration on 01/27/2031. |
| 01/24/2023 | Date of employee stock option grant with an exercise price of $72.94 and expiration on 01/24/2032, and restricted stock units vesting in three annual installments beginning on this date and expiring 01/24/2025. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17 and expiration on 01/24/2033, and restricted stock units vesting in three annual installments beginning on this date and expiring 01/24/2026. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72 and expiration on 01/26/2034, and restricted stock units vesting in three annual installments beginning on this date and expiring 01/26/2027. |
| 07/05/2024 | Date of the reported transaction involving the acquisition of phantom units. |
| 07/08/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.